SciBase Holding AB (Nasdaq First North: SCIB)

https://www.scibase.se

SciBase is a medical technology company that develops instruments for detection of skin cancer and other skin conditions. The Nevisense product can detect malignant melanoma, the most dangerous form of skin cancer, directly on the skin without needing to cut away suspected moles. The product is based on comprehensive research on Electrical Impedance Spectroscopy (EIS), and SciBase has conducted the largest study to date on the detection of malignant melanoma, in which Nevisense achieved excellent results. The study was published in May 2014 in the prestigious British Journal of Dermatology. Nevisense is approved for sale in the United States (PMA), Europe (CE mark) and Australia. In addition to detecting malignant melanoma, SciBase plans to increase the number of clinical applications for Nevisense. By using Nevisense as a platform, the Company may integrate functionality that uses the EIS method in assessing other skin diseases, such as non-melanoma skin cancer and atopic dermatitis. During 2017, SciBase launched a new type of electrode as well as new software and functionality for this purpose. Currently SciBase is conducting clinical trials with leading academic and clinical centers. The plan is to start commercialization of the first application in 2018. SciBase was founded in 1998 by Stig Ollmar, a researcher at The Karolinska Institute, and has its headquarters in Stockholm. The company is listed on the Nasdaq First North exchange since June 2, 2015 and Avanza is the Company's certified advisor. Business model The company’s business model is based on customers initially purchasing a Nevisense instrument then buying disposables (electrodes) on an on-going basis. Each electrode can only be used on one patient but on multiple moles or skin areas. *

	Start	1998-01-01 established
	Group	SciBase (Group)
	Predecessor	Karolinska Institutet
	Industry	Nevisense device
	Industry 2	diagnostic device
	Person	Grant, Simon (SciBase 201808 CEO)
	Person 2	Colérus, Michael (SciBase 201808 CFO)

	Region	Stockholm
	Country	Sweden
	City	n. a.
		Address record changed: 2020-12-02

Basic data	Employees	B: 11 to 50 (2018-06-30)
	Currency	SEK
	Annual sales	6,859,000 (sales, net (2017) 2017-12-31)
	Cash	85,231,000 (2018-06-30)

		* Document for »About Section«: SciBase AB. (8/21/18). "Press Release: Interim Report".

		Record changed: 2024-02-12

Picture Berlin Partner BIO 2024 International Convention San Diego 650x200px

More documents for SciBase (Group)

[1] SciBase AB. (8/21/18). "Press Release: Interim Report"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)